Pulmonary hypertension (PH) is an increasingly recognized complication of premature birth
and bronchopulmonary dysplasia (BPD), and is associated with increased morbidity and …

Bronchopulmonary dysplasia (BPD) is a major complication of preterm birth and has serious
adverse long‐term health consequences. The etiology of BPD is complex, multifactorial, and …

OBJECTIVE: To study antenatal risk factors and inflammatory responses during hypoxic
respiratory failure (HRF) in infants of very low gestational age (VLGA,≤ 32.0 weeks) …

Continuous improvements in perinatal care have allowed the survival of ever more
premature infants, making the task of protecting the extremely immature lung from injury …

In 2010, the National Institutes of Health Consensus Development Conference provided
therapeutic guidelines for the use of iNO; their primary conclusion was that apart from …

Background: Inhaled nitric oxide (iNO) is effective in term infants with hypoxic respiratory
failure. The pathophysiology of respiratory failure and the potential risks of iNO differ …

BACKGROUND: Nitric oxide (NO) has various roles in airway physiology and
pathophysiology. Monitoring exhaled NO levels is increasingly common to measure airways …

В лекции представлены современные взгляды на профилактику и лечение
бронхолегочной дисплазии у новорожденных детей. БИБЛИОМЕТРИЧЕСКИЕ …

Inhaled nitric oxide (iNO) is a well-established frontline therapy for term infants with
persistent pulmonary hypertension of the newborn (PPHN). PPHN typically occurs in full …

Inhaled nitric oxide (iNO) has been used not only for pulmonary vasodilation in term
neonates with hypoxemic respiratory failure, but also in preterm ones at risk of chronic lung …